Trabecular Bone Score, Bone Mineral Density and Bone Markers in Patients with Primary Hyperparathyroidism 2 Years After Parathyroidectomy

Abstract

Following a parathyroidectomy there is a bone mineral density (BMD) improvement in patients with primary hyperparathyroidism. However, data of bone microarchitecture are scarce. Trabecular bone score (TBS) estimates bone microarchitecture and could provide valuable information in those patients. The aim of this study is to assess TBS changes 2 years after successful surgery in a group of patients with primary hyperparathyroidism and correlate these results with changes in BMD and bone turnover markers. This is a prospective study including 32 patients. In all participants BMD and TBS were measured, before and 24 months after surgery. Biochemical data: serum calcium, PTH, 25-OH-vitamin D, beta-crosslaps, bone alkaline phosphatase, and osteocalcin. 25 female and 7 male patients, mean age 64.6±12.4 years, were included in the study. At baseline, BMD was low at: lumbar spine (T-score −2.19±1.31), total hip (−1.33±1.12), femoral neck (−1.75±0.84), and distal one-third radius (−2.74±1.68). Baseline TBS showed partially degraded microarchitecture (1.180±0.130). After parathyroidectomy lumbar spine BMD increased significantly (5.3±13.0%, p<0.05), as well as total hip (3.8±8.8%, p<0.05). There was an increase in TBS, but this was not significant. There was a correlation between TBS and BAP at baseline (r_s=0.73; p<0.01) and TBS and BAP 2 years after surgery (r_s=0.57, p<0.05). Although bone density improves 2 years after surgery in patients with primary hyperparathyroidism and there is a restoration of bone turnover markers, TBS is not completely restored. These results remark the necessity of longer periods of study, to confirm if bone microarchitecture could be completely restored after surgery.

Key words

trabecular bone score - hyperparathyroidism - bone mineral density

• References

• 1 Bandeira F, Cassibba S. Hyperparathyroidism and bone health. Curr Rheumatol Rep 2015; 17: 48
• 2 Silverberg SJ, Shane E, Jacobs TP. et al. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341: 1249-1255
• 3 Vignali E, Viccica G, Diacinti D. et al. Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 2009; 94: 2306-2312
• 4 De Geronimo S, Romagnoli E, Diacinti D. et al. The risk of fractures in postmenopausal women with primary hyperparathyroidism. Eur J Endocrinol 2006; 155: 415-420
• 5 Silva BC, Boutroy S, Zhang C. et al. Trabecular bone score (TBS) – A novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2013; 98: 1963-1970
• 6 Silverberg SJ, Clarke BL, Peacock M. et al. Current issues in the presentation of asymptomatic primary hyperparathyroidism: Proceedings of the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99: 3580-3594
• 7 Romagnoli E, Cipriani C, Nofroni I. et al. “Trabecular Bone Score” (TBS): An indirect measure of bone micro-architecture in postmenopausal patients with primary hyperparathyroidism. Bone 2013; 53: 154-159
• 8 Eller-Vainicher C, Filopanti M, Palmieri S. et al. Bone quality, as measured by trabecular bone score, in patients with primary hyperparathyroidism. Eur J Endocrinol 2013; 169: 155-162
• 9 Sankaran S, Gamble G, Bolland M. et al. Skeletal effects of interventions in mild primary hyperparathyroidism: A meta-analysis. J Clin Endocrinol Metab 2010; 95: 1653-1662
• 10 Hansen S, Hauge EM, Rasmussen L. et al. Parathyroidectomy improves bone geometry and microarchitecture in female patients with primary hyperparathyroidism: A one-year prospective controlled study using high-resolution peripheral quantitative computed tomography. J Bone Miner Res 2012; 27: 1150-1158
• 11 World Health Organization . Scientific Group Research on Menopause. WHO Technical Service Report Series 670. WHO; Geneva: 1998
• 12 Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
• 13 Bilezikian JP, Brandi ML, Eastell R. et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: Summary statement from the Fourth International Workshop. J Clin Endocrinol Metab 2014; 99: 3561-3569
• 14 Lee JH, Kim JH, Hong AR. et al. Skeletal effects of vitamin D deficiency among patients with primary hyperparathyroidism. Osteoporos Int 2017; 28: 1667-1674
• 15 Lundstam K, Heck A, Mollerup C. et al. Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2015; 100: 1359-1367
• 16 Tay YD, Cusano NE, Rubin MR. et al. Trabecular bone score in obese and nonobese subjects with primary hyperparathyroidism before and after parathyroidectomy. J Clin Endocrinol Metab 2018; 103: 1512-1521
• 17 Costa AG, Bilezikian JP. Bone turnover markers in primary hyperparathyroidism. J Clin Densitom 2013; 16: 22-27
• 18 Guo CY, Thomas WE, al-Dehaimi AW. et al. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 3487-3491
• 19 Christiansen P, Steiniche T, Brixen K. et al. Primary hyperparathyroidism: Biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 1997; 21: 93-99
• 20 Christiansen P, Steiniche T, Brixen K. et al. Primary hyperparathyroidism: Short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone 1999; 25: 237-244
• 21 Alonso S, Ferrero E, Donat M. et al. The usefulness of high pre-operative levels of serum type I collagen bone markers for the prediction of changes in bone mineral density after parathyroidectomy. J Endocrinol Invest 2012; 35: 640-644
• 22 Walker MD, Saeed I, Lee JA. et al. Effect of concomitant vitamin D deficiency or insufficiency on lumbar spine volumetric bone mineral density and trabecular bone score in primary hyperparathyroidism. Osteoporos Int 2016; 27: 3063-3071